Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout

Annals of the Rheumatic Diseases

Volumn 66, Issue 8, 2007, Pages 1056-1058

  Pascual, Eliseo ^a   Sivera, Francisca ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BENZBROMARONE; COLCHICINE; URATE; URIC ACID;

ADULT; AGED; ARTHROCENTESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYSTAL; DISEASE DURATION; GOUT; HUMAN; HUMAN TISSUE; HYPERURICEMIA; KNEE; MALE; METATARSOPHALANGEAL JOINT; PRIORITY JOURNAL; PROPHYLAXIS; SYNOVIAL FLUID;

ADULT; AGED; BENZBROMARONE; CHRONIC DISEASE; CRYSTALLIZATION; FOLLOW-UP STUDIES; GOUT; GOUT SUPPRESSANTS; HUMANS; KNEE JOINT; MALE; METATARSOPHALANGEAL JOINT; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; TIME FACTORS; TREATMENT OUTCOME; URIC ACID;

EID: 34547180887     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.060368     Document Type: Article

References (17)

1. Yu T-F, Gutman AB. Principles of current management of primary gout. Am J Med Sci 1967;254:893-907.
2. Yu T-F, Gutman AB. Mobilization of gouty tophi by protracted use of uricosuric agents. Am J Med 1951;11:765-9.
3. Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002;47:356-60.
4. Pascual E. Persistence of monosodium urate crystals, and low grade inflammation, in the synovial fluid of untreated gout. Arthritis Rheum 1991;34:141-5.
5. Pascual E, Batlle-Gualda E, Martínez A, Rosas J, Vela P. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med 1999;131:756-9.
6. Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001;28:577-80.
7. Pascual E, Castellano JA. Treatment with colchicine decreases the white cell counts in the synovial fluid of asymptomatic knees which contain monosodium urate crystals. J Rheumatol 1992;19:600-3.
8. Pascual E, Jovani V. A Quantitative study of the phagocytosis of urate crystals in the synovial fluid of asymptomatic joints of patients with gout. Br J Rheumatol 1995;34:724-6.
9. Lumbreras B, Pascual E, Frasquet J, Gonzalez-Salinas J, Rodríguez E, Hernandez-Aguado I. Analysis for crystals in synovial fluid: training of the analysts results in high consistency. Ann Rheum Dis 2005;64:612-5.
10. Pascual E, Jovani V. Synovial fluid analysis. Best Pract Res Clin Rheumatol 2005;19:371-86.
11. Loebl WY, Scott JT. Withdrawal of allopurinol in patients with gout. Ann Rheum Dis 1974;33:304-7.
12. Perez-Ruiz F, Alonso Ruiz A, Calabozo M, Herrero-Beites A, García-Erauskin G, Ruiz-Lucea E. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis 1998;57:545-9.
13. Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004;51:321-5.
14. Beutler AM, Rull M, Schlesinger N, Baker DG, Hoffman BI, Schumacher HR Jr. Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels. Clin Exp Rheumatol 2001;19:595.
15. Riedel AA, Nelson M, Joseph-Ridge N, Wallace K, MacDonald P, Becker M. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol 2004;31:1575-81.
16. Annemans L, Spaepen E, Nash C, Bonnemaire M, Gilbert T, Malier V. Medical management of chronic gout in the UK and Germany [abstract]. Ann Rheum Dis 2006;65(Suppl 2):430.
17. Pérez-Ruiz F. Treatment of gout before rheumatology consultation is far from that recommended [abstract]. Ann Rheum Dis 2006;65(Suppl 2):436.